Showing results (3011-3020 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1994
Phase II study of fludarabine phosphate for gastric adenocarcinoma. An Illinois Cancer Center trialL J Kilton, J B Ashenhurst, J L Wade, et al.Investigational New Drugs|February 1, 1993
Phase I trial of dihydrolenperone in lung cancer patients: a novel compound with in vitro activity against lung cancerB E Johnson, R Parker, C M Tsai, et al.Investigational New Drugs|February 1, 1993
Phase II trial of 13-cis-retinoic acid plus interferon-alpha in recurrent head and neck cancerN Voravud, S M Lippman, R S Weber, et al.Investigational New Drugs|January 1, 1984
Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral dosesS Kaplan, C Sessa, Y Willems, et al.Investigational New Drugs|January 1, 1984
Phase II study of epirubicin in advanced malignant melanomaM Lopez, C F Perno, P Papaldo, et al.Investigational New Drugs|January 1, 1984
m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group studyR D Hilgers, S S Legha, G A Johnston, et al.Investigational New Drugs|January 1, 1983
Phase I study of 4-demethoxydaunorubicinV Bonfante, L Ferrari, F Villani, et al.Investigational New Drugs|January 1, 1983
Activity of 4'-0-tetrahydropyranyladriamycin hydrochloride (THP-ADM) in a human tumor cloning systemK Inoue, M Arakawa, H Miyamoto, et al.Investigational New Drugs|January 1, 1983
Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cellsT L Jiang, R H Liu, S E SalmonInvestigational New Drugs|January 1, 1983
Application of a microsomal drug activation system in a human tumor cloning assayH R Metelmann, D D Von HoffPageof 372